cnetsadmin

/cnetsadmin

About cnetsadmin

This author has not yet filled in any details.
So far cnetsadmin has created 45 blog entries.

Patient Input – Treatment with Telotristat

TELOTRISTAT is an adjunct to somatostatin analogue therapy for the long-term treatment of carcinoid syndrome to improve symptom control in adult patients with metastatic neuroendocrine tumours.The company who makes telotristat [...]

By | 2018-09-03T18:47:17+00:00 September 3rd, 2018|Survey, Treatment News|Comments Off on Patient Input – Treatment with Telotristat

ARETHA FRANKLIN DIED FROM NEUROENDOCRINE CANCER

RIP THE GREAT ARETHA FRANKLIN Aretha Franklin, the Queen of Soul, passed away from neuroendocrine cancer (NETs) of the pancreas, the very same cancer that killed Apple [...]

By | 2018-09-03T11:14:07+00:00 August 17th, 2018|News|Comments Off on ARETHA FRANKLIN DIED FROM NEUROENDOCRINE CANCER

NET Research Priorities Survey Results

In March CNETS Canada reached out to the patient community through an online, anonymous survey to gather feedback and input on setting the research priorities for CNETS Canada sponsored grants [...]

By | 2018-09-22T00:19:01+00:00 August 15th, 2018|Research, Survey|Comments Off on NET Research Priorities Survey Results

PRRT Program at L’Hôtel-Dieu de Québec

Une approche novatrice contre le cancer à l'Hôtel-Dieu de Québec « Une nouvelle approche médicale attire à Québec des Canadiens, et même des Américains, atteints d'une forme rare de cancer. Le traitement [...]

By | 2018-06-19T15:58:17+00:00 June 19th, 2018|News|Comments Off on PRRT Program at L’Hôtel-Dieu de Québec

PMPRB Patient Group Consultation Submission

Patient Groups send a strong message to the Federal Minister of Health: Patient voices must be heard. We ask the @CDNMinHealth to halt the review of drug prices and move to [...]

By | 2018-05-07T18:28:10+00:00 February 15th, 2018|News|Comments Off on PMPRB Patient Group Consultation Submission

Health Canada approves Ipsen’s Somatuline® Autogel® for the treatment of carcinoid syndrome in adult patients with neuroendocrine tumours (NETs)

Somatuline Autogel is the first and only somatostatin analog (SSA) approved in Canada to treat enteropancreatic neuroendocrine tumours and carcinoid syndrome. Februaury 13th, 2018 - Health Canada announced the approval [...]

By | 2018-05-07T18:28:10+00:00 February 13th, 2018|Treatment News|Comments Off on Health Canada approves Ipsen’s Somatuline® Autogel® for the treatment of carcinoid syndrome in adult patients with neuroendocrine tumours (NETs)

Raising NET Cancer Awareness on World Cancer Day

CNETS Canada Montreal Support Group Leaders Donna Hillier, Daniel Opoku and volunteer Marie-Anne Risdon set up a kiosk at the Ceders Cancer Foundation - CEDARS CANSUPPORT WORLD CANCER DAY, providing [...]

By | 2018-05-07T18:28:10+00:00 February 6th, 2018|News|Comments Off on Raising NET Cancer Awareness on World Cancer Day